Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 10/20 | 0.42 |
| ▸ | ACACA | Q13085 | 10/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 4/20 | 0.32 |
| ▸ | GSK3A | P49840 | 1/20 | 0.32 |
| ▸ | WEE1 | P30291 | 1/20 | 0.32 |
| ▸ | ADAMTS5 | Q9UNA0 | 2/20 | 0.31 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4546184 | 0.88 | ACACB (0.39) | ACACBACACARECQLGSK3BGSK3A | |
| SCHEMBL4546185 | 0.87 | ACACB (0.50) | ACACBACACARECQLGSK3BGSK3A | |
| SCHEMBL4549943 | 0.83 | ACACB (0.43) | ACACBACACARECQLGSK3BGSK3A | |
| SCHEMBL4546183 | 0.81 | ACACB (0.47) | ACACBACACARECQLGSK3BGSK3A | |
| SCHEMBL4546200 | 0.81 | ACACB (0.46) | ACACBACACARECQL | |
| SCHEMBL4546182 | 0.80 | ACACB (0.35) | ACACBACACA | |
| SCHEMBL4546194 | 0.78 | ACACB (0.40) | ACACBACACARECQL | |
| SCHEMBL811962 | 0.75 | ACACB (0.55) | ACACBACACA | |
| SCHEMBL4549929 | 0.74 | ACACB (0.43) | ACACBACACARECQL | |
| SCHEMBL15472969 | 0.74 | ACACB (0.56) | ACACBACACARECQLGSK3BGSK3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8173697-B2 | Alkoxyalkyl-substituted cyclic keto-enols | BAYER CROPSCIENCE AG (DE) | 2012-05-08 | — | — | US | disclosed |
| US-20090298828-A1 | Alkoxyalkyl-Substituted Cyclic Keto-Enols | BAYER CROPSCIENCE AG (DE) | 2009-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090298828-A1 | Alkoxyalkyl-Substituted Cyclic Keto-Enols | DDT, AKR1D1, EBP | ACACB 249/4885ACACA 529/4885RECQL 2752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.